SHC
Overvalued by 152.5% based on the discounted cash flow analysis.
Market cap | $3.47 Billion |
---|---|
Enterprise Value | $3.17 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.16 |
Beta | 1.89 |
Outstanding Shares | 283,558,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 139.92 |
---|---|
PEG | -45.18 |
Price to Sales | 4.08 |
Price to Book Ratio | 12.24 |
Enterprise Value to Revenue | 2.86 |
Enterprise Value to EBIT | 13.48 |
Enterprise Value to Net Income | 127 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...